New Injectable Gels Toughen up after Entering the Body
News Nov 16, 2012
Gels that can be injected into the body, carrying drugs or cells that regenerate damaged tissue, hold promise for treating many types of disease, including cancer. However, these injectable gels don’t always maintain their solid structure once inside the body.
MIT chemical engineers have now designed an injectable gel that responds to the body’s high temperature by forming a reinforcing network that makes the gel much more durable, allowing it to function over a longer period of time.
The research team, led by Bradley Olsen, an assistant professor of chemical engineering, described the new gels in a recent issue of the journal Advanced Functional Materials. Lead author of the paper is Matthew Glassman, a graduate student in Olsen’s lab. Jacqueline Chan, a former visiting student at MIT, is also an author.
Olsen and his students worked with a family of gels known as shear thinning hydrogels, which have a unique ability to switch between solid-like and liquid-like states. When exposed to mechanical stress — such as being pushed through an injection needle — these gels flow like fluid. But once inside the body, the gels return to their normal solid-like state.
However, a drawback of these materials is that after they are injected into the body, they are still vulnerable to mechanical stresses. If such stresses make them undergo the transition to a liquid-like state again, they can fall apart.
“Shear thinning is inherently not durable,” Olsen says. “How do you undergo a transition from not durable, which is required to be injected, to very durable, which is required for a long, useful implant life?”
The MIT team answered that question by creating a reinforcing network within their gels that is activated only when the gel is heated to body temperature (37 degrees Celsius).
Shear thinning gels can be made with many different materials (including polymers such as polyethylene glycol, or PEG), but Olsen’s lab is focusing on protein hydrogels, which are appealing because they can be designed relatively easily to promote biological functions such as cellular adhesion and cell migration.
The protein hydrogels in this study consist of loosely packed proteins held together by links between protein segments known as coiled coils, which form when two or three helical proteins coil into a ropelike structure.
The MIT researchers designed their hydrogel to include a second reinforcing network, which takes shape when polymers attached to the ends of each protein bind together. At lower temperatures, these polymers are soluble in water, so they float freely in the gel. However, when heated to body temperature, they become insoluble and separate out of the watery solution. This allows them to join together and form a sturdy grid within the gel, making it much more durable.
The researchers found that gels with this reinforcing network were much slower to degrade when exposed to mechanical stress and were significantly stiffer. This offers a promising way to thwart the tendency of shear thinning materials to erode once in the body, says Jason Burdick, an associate professor of bioengineering at the University of Pennsylvania.
“Building in this secondary network based on a different type of mechanism is a very elegant way to overcome that obstacle through material design,” says Burdick, who was not part of the research team.
Another advantage of these gels is that they can be tuned to degrade over time, which would be useful for long-term drug release. The researchers are now working on ways to control this feature, as well as incorporating different types of biological functions into the gels.
The research was funded by the U.S. Army Research Office through MIT's Institute for Soldier Nanotechnologies (ISN). Potential applications of these nanostructured gels to soldier medicine include preventing blood loss, accelerating wound healing and protecting against infections and disease.
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE
Oligonucleotide Drug Producers Report on Drug ImpuritiesNews
A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.READ MORE
Faster, More Accurate Cancer Detection Using NanoparticlesNews
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.READ MORE